Technical Analysis for ZCOR - Egalet Corp

Grade Last Price % Change Price Change
grade D 1.9 -5.00% -0.1000
ZCOR closed down 5.0 percent on Wednesday, August 14, 2019, on 8 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A N/A Down
See historical ZCOR trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%

Older signals for ZCOR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
RTT Euphoriants Pharmaceutical Psychoactive Drugs Chemical Compounds Morphinans Heroin Opioids Morphine Oxycodone Acute And Chronic Pain Analgesic Pain Products Alternative Treatments Hydrocodone Immediate Release Oxycodone Product Morphine Product Nasal Spray Short Term Management Sprix Nasal Spray
Is ZCOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 3.0
52 Week Low 1.9
Average Volume 22,176
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 2.305
10-Day Moving Average 2.224
Average True Range 0.1231
ADX 35.99
+DI 24.7041
-DI 57.5482
Chandelier Exit (Long, 3 ATRs ) 2.4357
Chandelier Exit (Short, 3 ATRs ) 2.2693
Upper Bollinger Band 2.7087
Lower Bollinger Band 1.9013
Percent B (%b) 0.0
BandWidth 35.0282
MACD Line -0.1522
MACD Signal Line -0.1337
MACD Histogram -0.0184
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.9750
Resistance 3 (R3) 1.9833 1.9667 1.9625
Resistance 2 (R2) 1.9667 1.9476 1.9625 1.9583
Resistance 1 (R1) 1.9333 1.9358 1.9250 1.9250 1.9542
Pivot Point 1.9167 1.9167 1.9125 1.9125 1.9167
Support 1 (S1) 1.8833 1.8976 1.8750 1.8750 1.8458
Support 2 (S2) 1.8667 1.8858 1.8625 1.8417
Support 3 (S3) 1.8333 1.8667 1.8375
Support 4 (S4) 1.8250